Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

Presentation TCT 2025

How Do I Decide on MCS Support in Elective Coronary Intervention?

Presenter: Luca Testa

October 25, 2025

Optimal Revascularization Strategies in Patient with DM: Case Presentation

Presentation TCT 2023

Complex PCI in patients with DM: Cases Presentation

Presenter: Luca Testa

October 26, 2023

Presentation TCT 2022

Diabetes and DES+DCB platform: the perfect match

Presenter: Luca Testa

September 17, 2022

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

Presentation TCT 2020

TRANSIT: Treatment of Failed TAVR With TAVR

Presenter: Luca Testa

October 17, 2020

Presentation TCT 2020

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

Presenter: Luca Testa

October 14, 2020

Presentation JIM 2020

The Abluminus DES+: from the technical features to the clinical program

Presenter: Luca Testa

February 13, 2020

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

Presentation JIM 2019

How to approach bicuspid aortic stenosis: sizing, valve type and implantation

Presenter: Luca Testa

February 15, 2019

Presentation JIM 2019

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

Presenter: Luca Testa

February 14, 2019

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

Presentation JIM 2018

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

Presenter: Luca Testa

February 22, 2018

Presentation JIM 2018

Primary PCI: Male, 69 y/o, Chest pain ED Melegnano

Presenter: Lucas Testa

February 21, 2018

Presentation TCT 2017

Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Luca Testa

October 31, 2017

Presentation EuroPCR 2017

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Presenter: Luca Testa

May 19, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

Advertisement

How Do I Decide on MCS Support in Elective Coronary Intervention?

Complex PCI in patients with DM: Cases Presentation

Diabetes and DES+DCB platform: the perfect match

More DAPT Duration Data, More Calls to Tailor to Individual Patients

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

TRANSIT: Treatment of Failed TAVR With TAVR

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

The Abluminus DES+: from the technical features to the clinical program

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

How to approach bicuspid aortic stenosis: sizing, valve type and implantation

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

Primary PCI: Male, 69 y/o, Chest pain ED Melegnano

Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content